GTR Test Accession:
Help
GTR000507010.2
CAP
Last updated in GTR:
2022-06-16
View version history
GTR000507010.3,
last updated:
2024-07-05
GTR000507010.2,
last updated:
2022-06-16
GTR000507010.1,
registered in GTR:
2021-06-23
Last annual review date for the lab: 2023-06-16
Past due
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Risk Assessment; ...
Conditions (1):
Help
Cystic fibrosis
Genes (1):
Help
CFTR (7q31.2)
Methods (1):
Help
Molecular Genetics - Mutation scanning of select exons: Oligonucleotide Ligation Assay (OLA)
Target population: Help
Patients with a diagnosis of Cystic fibrosis, CF-related disorder, Sweat …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Establish or confirm diagnosis
Ordering Information
Offered by:
Help
Test short name:
Help
CFTR Targeted mutation panel
Manufacturer's name:
Help
xTAG® Cystic Fibrosis V2 (CF60)v2.00, Luminex Molecular Diagnostics
Specimen Source:
Help
- Peripheral (whole) blood
- View specimen requirements
Who can order: Help
- Genetic Counselor
- Health Care Provider
- Licensed Physician
Test Order Code:
Help
CFDXL
View other test codes
View other test codes
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Provide appropriate sample, relevant clinical information and a completed requisition form.
Order URL
Order URL
Test development:
Help
FDA-reviewed (has FDA test name)
Informed consent required:
Help
Based on applicable state law
Test strategy:
Help
https://www.pathology.med.umich.edu/handbook/#/details/972
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Lab contact for this test
Conditions
Help
Total conditions: 1
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 1
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument
Mutation scanning of select exons
Oligonucleotide Ligation Assay (OLA)
Luminex 2000
Clinical Information
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Risk Assessment;
Screening
Clinical utility:
Help
Establish or confirm diagnosis
Target population:
Help
Patients with a diagnosis of Cystic fibrosis, CF-related disorder, Sweat chloride elevation without CF, idiopathic Pancreatitis, Bronchiectasis with or without elevated sweat chloride, neonatal Hypertrypsinemia.
Variant Interpretation:
What is the protocol for interpreting a variation as a VUS?
Help
Follow ACMG guidelines, suggest family study
Follow ACMG guidelines, suggest family study
Are family members with defined clinical status recruited to assess significance of VUS without charge?
Help
No.
No.
Will the lab re-contact the ordering physician if variant interpretation changes?
Help
Yes. by Phone or secure email
Yes. by Phone or secure email
Recommended fields not provided:
Clinical validity,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Procedure:
Help
Using new aliquot/sample
Test Confirmation:
Help
Using new aliquot/sample
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Analytical Sensitivity 95% Accuracy 100% Precision 100%
Assay limitations:
Help
Targeted screening for 60 variant in the CFTR gene ONLY. Does not detect any other mutations in the CFTR gene. Does not detect large deletions, duplications and rearrangements in the CFTR gene region.
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
VUS:
Software used to interpret novel variations
Help
SIFT, PolyPhen2, RESCUE-ESE Web Server, Berkeley Drosophila Genome Project
Laboratory's policy on reporting novel variations Help
Contact ordering physician by phone and by routine report; recommend clinical genetics follow up and/or genetic counseling and parental testing
SIFT, PolyPhen2, RESCUE-ESE Web Server, Berkeley Drosophila Genome Project
Laboratory's policy on reporting novel variations Help
Contact ordering physician by phone and by routine report; recommend clinical genetics follow up and/or genetic counseling and parental testing
Recommended fields not provided:
Citations to support assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
FDA exercises enforcement discretion
Additional Information
Suggested reading:
Clinical resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.